T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma

Por Postow, Michael, Manuel, Manuarii, Wong, Phillip, Yuan, Jianda, Noel, Marlene, Courtier, Anais, Pasqual, Nicolas, Wolchok, Jedd D
Publicado no J Immunother Cancer (2014)

ImmunTraCkeR(®) as a reliable TCR repertoire profiling tool to understand immune response and to explore immunotherapy biomarkers

Por Tanneau, Isabelle, Nondé, Audrey, Courtier, Anaïs, Parmentier, Gilles, Noël, Marlène, Grivès, Audrey, Perez, Solène, Plantier, Nadia, Mouret, Jean-François, Filipe-Santos, Orchidée, Manuel, Manuarii
Publicado em 2013

Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma

Por Postow, Michael A., Manuel, Manuarii, Wong, Phillip, Yuan, Jianda, Dong, Zhiwan, Liu, Cailian, Perez, Solène, Tanneau, Isabelle, Noel, Marlène, Courtier, Anaïs, Pasqual, Nicolas, Wolchok, Jedd D.
Publicado no J Immunother Cancer (2015)

Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients

Por Manuel, Manuarii, Tredan, Olivier, Bachelot, Thomas, Clapisson, Gilles, Courtier, Anais, Parmentier, Gilles, Rabeony, Tioka, Grives, Audrey, Perez, Solène, Mouret, Jean-François, Perol, David, Chabaud, Sylvie, Ray-Coquard, Isabelle, Labidi-Galy, Intidhar, Heudel, Pierre, Pierga, Jean-Yves, Caux, Christophe, Blay, Jean-Yves, Pasqual, Nicolas, Ménétrier-Caux, Christine
Publicado em 2012